Table 1.
Demographic and clinical characteristics of subjects and drug dose.
Fig 1.
Levodopa and levodopa equivalent dose.
Levodopa (a) and levodopa equivalent dose (b) of each subjects. Left and right ends of each light line indicate initial titration dose and dose at onset of LID of each subject, respectively. The mean doses of subject groups are expressed as heavy lines.
Fig 2.
Time to onset of levodopa-induced dyskinesia and drug dose.
Correlation between time to onset of levodopa-induced dyskinesia (LID) and initial titrating levodopa dose (a), time to LID and initial titrating levodopa-equivalent dose (b), time to LID and rate of increase in levodopa dose (c), and time to LID and rate of increase in levodopa-equivalent dose (d).
Table 2.
Results of multiple linear regression analyses to predict time to levodopa-induced dyskinesia.